Kwality Pharmaceuticals Share Price
3281.00-70.70 (-2.11%)
+97.34% past 1 Year
Kwality Pharmaceuticals Ltd. (formerly Kwality Pharmaceuticals Pvt. Ltd.) is a pharmaceutical formation company. It is engaged in manufacturing finished pharmaceutical formulations in dosage form. The company manufacture and export pharmaceutical
Corporate filings & documents
Announcements
Regularization of appointment of Mr Swanith Kapoor as Director and reappointment of Mr Aditya Arora as WTD of the company
1 day agoSCRUTINIZER REPORT OF AGM E-VOTING IS ATTACHED
1 day agoProceedings of 43rd Annual General Meeting attached herewith.
3 days agoProceedings of 43rd Annual General Meeting attached herewith.
3 days agoNewspaper Publication of Unaudited Financial Results for the quarter ended June 30 2026.
3 weeks agoNewspaper Publication of Unaudited Financial Results for the quarter ended June 30 2026.
3 weeks agoNewspaper Publication of Notice of 43rd Annual General Meeting.
3 weeks agoNewspaper Publication of Notice of 43rd Annual General Meeting.
3 weeks agoOutcome of Investors/Analysts Meeting held on August 10 2026
3 weeks agoOutcome of Investors/Analysts Meeting held on August 10 2026
3 weeks agoTranscript of Earnings Conference Call - Q1FY27
3 weeks agoTranscript of Earnings Conference Call - Q1FY27
3 weeks agoTranscript of Earnings Conference Call - Q1FY27
3 weeks agoTranscript of Earnings Conference Call - Q1FY27
3 weeks agoInvestor Presentation for quarter ended June 30 2026.
3 weeks agoInvestor Presentation for quarter ended June 30 2026.
3 weeks agoFinancial Results for Quarter Ended June 30 2026.
3 weeks agoFinancial Results for Quarter Ended June 30 2026.
3 weeks agoSubmission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations 2015
3 weeks agoSubmission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations 2015
3 weeks agoNOTICE OF 43RD AGM IS ENCLOSED
3 weeks agoPursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations 2015 as amended ( Listing Regulations) please find attached herewith the Annual Report of the Company for the FY 2025-26 along with Notice convening the 43rd Annual General Meeting ("AGM") of the Company on Monday 31st August 2026 at 12 :00 Noon. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OA VM).
3 weeks agoIntimation of Book Closure.
3 weeks agoIntimation of Book Closure.
3 weeks agoIntimation of 43rd AGM
3 weeks agoIntimation of 43rd AGM
3 weeks agoThis is to inform you pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the Board of Directors of the Company at its meeting held today i.e. Saturday August 08 2026 inter alia has taken the following decisions:-1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31 2026 under section 134 of the Companies Act 2013.2. The Board of Directors of the Company have considered and approved the Notice of 43rd Annual General Meeting of the Company.3. The Board has approved the day date time and calendar of events and Notice of 43rd Annual General Meeting of the company to be held on 31st August 2026 at 12:00 noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM) * other details as per attachment*
3 weeks agoThis is to inform you pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the Board of Directors of the Company at its meeting held today i.e. Saturday August 08 2026 inter alia has taken the following decisions:-1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31 2026 under section 134 of the Companies Act 2013.2. The Board of Directors of the Company have considered and approved the Notice of 43rd Annual General Meeting of the Company.3. The Board has approved the day date time and calendar of events and Notice of 43rd Annual General Meeting of the company to be held on 31st August 2026 at 12:00 noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM) * other details as per attachment*
3 weeks agoIntimation of Earnings Conference Call for Q1 FY 2026-27
1 month agoIntimation of Earnings Conference Call for Q1 FY 2026-27
1 month agoIntimation of Earnings Conference Call for Q1 FY 2026-27
1 month agoIntimation of Earnings Conference Call for Q1 FY 2026-27
1 month agoKwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30 2026.
1 month agoKwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30 2026.
1 month agoKwality Pharmaceuticals receives CDSCO Nod to Initiate Preclinical Pilot Batches of Pembroluzimab
1 month agoKwality Pharmaceuticals receives CDSCO Nod to Initiate Preclinical Pilot Batches of Pembroluzimab
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30-06-2026.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30-06-2026.
1 month agoIntimation of Closure of Trading Window
2 months agoIntimation of Closure of Trading Window
2 months agoResignation of Mr. Kartik Kapur Independent Director of the Company.
3 months agoResignation of Mr. Kartik Kapur Independent Director of the Company.
3 months agoAppointment of Mr. Swanith Kapoor as Additional (Non-Executive Independent) Director and Resignation of Mr. Kartik Kapur Independent Director of the Company.
3 months agoAppointment of Mr. Swanith Kapoor as Additional (Non-Executive Independent) Director and Resignation of Mr. Kartik Kapur Independent Director of the Company.
3 months agoAnnual Secretarial Compliance Report for the year ended 31-03-2026 is enclosed herewith
3 months agoAudio recording of quarterly earning conference call
3 months agoAudio recording of quarterly earning conference call
3 months agoNewspaper Publication of Audited Financial Results for the quarter and year ended March 31 2026.
3 months agoNewspaper Publication of Audited Financial Results for the quarter and year ended March 31 2026.
3 months agoTranscript of Earning Conference Call of Q4FY2026.
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
May 2026
Feb 2026
ConcallPresentation
May 2024
ConcallPresentation
May 2023
ConcallPresentation
May 2022
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
6th Mile Stone Village Nagkalan Majitha Road Amritsar Punjab PIN: 143601 Tel No: 08558820862 / 63 / 9915743720 Fax No: NULL Email: [email protected] / [email protected] Internet: www.kwalitypharma.com
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Gurpreet Kaur, Company Secretary & Compliance Officer
Ramesh Kumar, Managing Director
Ajay Kumar Arora , Whole Time Director
Anju Arora, Whole Time Director
Geeta Arora, Whole Time Director
Aditya Arora, Whole Time Director & Chief Financial Officer
Vinod Kumar Sharma, Non Executive Independent Director
Prashanth Vellanki, Non Executive Independent Director
Preetmohinder Singh Bedi, Non Executive Independent Director
Bhavesh Mahajan, Non Executive Independent Director
Swanith Kapoor, Non Executive Independent Director
Details
BSE 539997
NSE KPL
ISIN INE552U01010